The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study.

Clin Kidney J · 2018 · PMC6275453 · PMID 30524708

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

This effect was driven by a highly significant 38% [HR 0.62 (95% CI 0.49–0.77)] reduction in CV death.

also in 132,142 other papers

nominally significantno p-value reported

This included a nominally significant reduction in the necessity to start RRT [HR 0.45 (95% CI 0.21–0.97)].

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.